GAD2 and type 1 diabetes mellitus: Along the same lines, a study on type 1 diabetes (T1D) used an ex vivo activation approach with the known diabetes antigen glutamic acid decarboxylase 65 (GAD65) and incorporated specificity prediction with the GLIPH algorithm.